Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Cerebral Palsy v1.19 SPATA5L1 Zornitza Stark Phenotypes for gene: SPATA5L1 were changed from Intellectual disability; spastic-dystonic cerebral palsy; epilepsy; hearing loss to Neurodevelopmental disorder with hearing loss and spasticity, MIM# 619616
Cerebral Palsy v1.18 SPATA5L1 Zornitza Stark reviewed gene: SPATA5L1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurodevelopmental disorder with hearing loss and spasticity, MIM# 619616; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Cerebral Palsy v1.18 SPATA5L1 Zornitza Stark Marked gene: SPATA5L1 as ready
Cerebral Palsy v1.18 SPATA5L1 Zornitza Stark Gene: spata5l1 has been classified as Green List (High Evidence).
Cerebral Palsy v1.18 SPATA5L1 Zornitza Stark Classified gene: SPATA5L1 as Green List (high evidence)
Cerebral Palsy v1.18 SPATA5L1 Zornitza Stark Gene: spata5l1 has been classified as Green List (High Evidence).
Cerebral Palsy v1.17 SPATA5L1 Paul De Fazio gene: SPATA5L1 was added
gene: SPATA5L1 was added to Cerebral Palsy. Sources: Literature
Mode of inheritance for gene: SPATA5L1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SPATA5L1 were set to 34626583
Phenotypes for gene: SPATA5L1 were set to Intellectual disability; spastic-dystonic cerebral palsy; epilepsy; hearing loss
Review for gene: SPATA5L1 was set to GREEN
gene: SPATA5L1 was marked as current diagnostic
Added comment: 47 individuals from 26 unrelated families from various ethnicities with biallelic variants reported. Phenotypes include ID, hearing impairment, movement disorder, abnormal MRI, hypotonia, visual impairment, epilepsy, and microcephaly.

Approximately two-thirds of individuals had spastic-dystonic cerebral palsy.
Sources: Literature